PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1454048
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1454048
Chronic Cough Market Forecasts to 2030 - Global Analysis By Drug Class, Route of Administration, Distribution Channel, End User and By Geography
According to Stratistics MRC, the Global Chronic Cough Market is accounted for $7.3 billion in 2023 and is expected to reach $14.3 billion by 2030 growing at a CAGR of 10.0% during the forecast period. A chronic cough is a persistent cough that lasts for more than eight weeks in adults or four weeks in children, according to most medical definitions. It's a symptom rather than a disease itself and can be caused by a variety of underlying conditions such as asthma, allergies, gastroesophageal reflux disease (GERD), postnasal drip, smoking, chronic bronchitis, or certain medications. Chronic cough can significantly impact quality of life and may require medical evaluation to determine the underlying cause and appropriate treatment.
According to the National Health Policy 2017, India, premature mortality due to non-communicable diseases, including chronic cough, will be reduced by ~ 25% by 2025.
Market Dynamics:
Driver:
Increasing prevalence of chronic respiratory diseases
The market is witnessing a notable rise in chronic respiratory diseases prevalence. This surge is attributed to various factors such as environmental pollution, lifestyle changes, and aging populations. Chronic respiratory conditions are increasingly prevalent, contributing to the expansion of the market. With growing awareness and diagnostic advancements, the demand for effective treatments for chronic respiratory ailments continues to escalate, driving further growth in this sector.
Restraint:
Side effects and safety concerns
Common side effects of pharmaceutical treatments for chronic cough include drowsiness, dizziness, and gastrointestinal disturbances. There are safety concerns regarding potential drug interactions and the risk of dependency or abuse with certain medications. Patients with underlying medical conditions such as cardiovascular issues or respiratory disorders may face heightened risks. It's imperative for healthcare providers to carefully assess each patient's medical history and closely monitor treatment outcomes to mitigate these concerns. Hence, these are the factors impeding the growth of the market.
Opportunity:
Rising healthcare expenditure
The market is witnessing a notable surge in healthcare expenditure, driven by various factors such as increased diagnosis rates, expanding patient populations, and advancements in treatment options. As awareness grows and more patients seek medical attention for chronic cough, healthcare spending continues to rise steadily. This trend underscores the significance of addressing chronic cough as a healthcare priority and highlights the need for continued investment in research, development, and patient care initiatives within this market segment.
Threat:
High cost of treatment
The market grapples with the significant challenge of high treatment costs, posing a considerable burden on patients and healthcare systems alike. The expenses associated with therapies and ongoing management contribute to financial strain for individuals seeking relief from this persistent condition. Despite advancements in medical technology and treatment modalities, the steep costs remain a barrier to access for many, underscoring the pressing need for affordable and sustainable solutions within the healthcare landscape.
Covid-19 Impact:
The COVID-19 pandemic significantly affected the Chronic Cough market, causing disruptions in diagnosis, treatment, and patient care. Lockdown measures, reduced healthcare access, and prioritization of resources towards managing COVID-19 led to delays in chronic cough management. Additionally, fear of visiting healthcare facilities deterred patients from seeking timely treatment. Consequently, there was a decline in diagnosis rates and treatment initiation, impacting market growth. Telemedicine emerged as a preferred mode for consultation, offering some relief amidst restrictions but couldn't fully compensate for in-person evaluations.
The decongestants segment is expected to be the largest during the forecast period
The decongestants segment is expected to be the largest during the forecast period driven by increasing awareness and prevalence of respiratory conditions. They alleviate nasal congestion and postnasal drip, addressing underlying causes of persistent coughing. Pharmaceutical companies actively engage in research and development to enhance existing formulations and introduce novel decongestant products. This dynamic market landscape underscores the importance of effective decongestants in managing chronic cough and related respiratory ailments.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is expected to have the highest CAGR during the forecast period. Leading hospitals specializing in respiratory health, such as renowned academic medical centers and pulmonology departments, are crucial players. These hospitals offer comprehensive services, including diagnostic imaging, pulmonary function testing, and access to multidisciplinary teams of specialists. Additionally, they provide cutting-edge therapies and clinical trials, ensuring patients receive optimal care and management for their chronic cough conditions.
Region with largest share:
North America is projected to hold the largest market share during the forecast period. Pharmaceutical interventions, including antitussive medications and targeted therapies, dominate the market landscape. Additionally, a surge in research and development activities aimed at novel treatment modalities further propels market expansion. With a focus on improving patient outcomes and quality of life, the market continues to evolve with promising opportunities for innovation and investment.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to increasing pollution levels, rising geriatric population, changing lifestyles leading to higher incidence of respiratory diseases, and growing awareness about available treatment options. Additionally, there was growing interest in non-pharmacological interventions such as speech therapy, breathing exercises, and lifestyle modifications. Regulatory frameworks governing the market varied across countries in the region, influencing market dynamics and product availability.
Key players in the market
Some of the key players in Chronic Cough market include Teva Pharmaceuticals Industries, Mylan N.V., Amneal Pharmaceuticals LLC, Novartis AG, Hikma Pharmaceuticals Plc, Bayer AG, GSK plc, Aurobindo Pharma, Apotex Inc., Micro Labs Ltd, AstraZeneca plc, Sun Pharmaceuticals Industries Ltd, Cipla Limited, Glenmark Pharmaceuticals Ltd, NeRRe Therapeutics and Pfizer Inc.
Key Developments:
In September 2022, Pfizer Inc., a US-based biopharmaceutical company, acquired ASX-listed digital health startup ResApp Health for $115 million. With this acquisition, Pfizer aimed to enhance its product portfolio and expand its presence in crucial healthcare technology areas.
In January 2022, Merck announced Gefapixant, a non-narcotic, oral selective P2X3 receptor antagonist for the treatment of patients with RCC or unexplained chronic cough (UCC), was approved by FDA.
Drug Classes Covered:
- Antibiotics
- Acid Blockers
- Corticosteroids
- Decongestants
- Combination Drug
- Antihistamines
- Other Drug Classes
Route of Administrations Covered:
- Inhalational
- Oral
- Injectable
- Other Route of Administrations
Distribution Channels Covered:
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
End Users Covered:
- Speciality Centres
- Homecare
- Hospitals
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 End User Analysis
- 3.7 Emerging Markets
- 3.8 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Chronic Cough Market, By Drug Class
- 5.1 Introduction
- 5.2 Antibiotics
- 5.3 Acid Blockers
- 5.4 Corticosteroids
- 5.5 Decongestants
- 5.6 Combination Drug
- 5.7 Antihistamines
- 5.8 Other Drug Classes
6 Global Chronic Cough Market, By Route of Administration
- 6.1 Introduction
- 6.2 Inhalational
- 6.3 Oral
- 6.4 Injectable
- 6.5 Other Route of Administrations
7 Global Chronic Cough Market, By Distribution Channel
- 7.1 Introduction
- 7.2 Retail Pharmacy
- 7.3 Hospital Pharmacy
- 7.4 Online Pharmacy
8 Global Chronic Cough Market, By End User
- 8.1 Introduction
- 8.2 Speciality Centres
- 8.3 Homecare
- 8.4 Hospitals
- 8.5 Other End Users
9 Global Chronic Cough Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Teva Pharmaceuticals Industries
- 11.2 Mylan N.V.
- 11.3 Amneal Pharmaceuticals LLC
- 11.4 Novartis AG
- 11.5 Hikma Pharmaceuticals Plc
- 11.6 Bayer AG
- 11.7 GSK plc
- 11.8 Aurobindo Pharma
- 11.9 Apotex Inc.
- 11.10 Micro Labs Ltd
- 11.11 AstraZeneca plc
- 11.12 Sun Pharmaceuticals Industries Ltd
- 11.13 Cipla Limited
- 11.14 Glenmark Pharmaceuticals Ltd
- 11.15 NeRRe Therapeutics
- 11.16 Pfizer Inc.
List of Tables
- Table 1 Global Chronic Cough Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Chronic Cough Market Outlook, By Drug Class (2021-2030) ($MN)
- Table 3 Global Chronic Cough Market Outlook, By Antibiotics (2021-2030) ($MN)
- Table 4 Global Chronic Cough Market Outlook, By Acid Blockers (2021-2030) ($MN)
- Table 5 Global Chronic Cough Market Outlook, By Corticosteroids (2021-2030) ($MN)
- Table 6 Global Chronic Cough Market Outlook, By Decongestants (2021-2030) ($MN)
- Table 7 Global Chronic Cough Market Outlook, By Combination Drug (2021-2030) ($MN)
- Table 8 Global Chronic Cough Market Outlook, By Antihistamines (2021-2030) ($MN)
- Table 9 Global Chronic Cough Market Outlook, By Other Drug Classes (2021-2030) ($MN)
- Table 10 Global Chronic Cough Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 11 Global Chronic Cough Market Outlook, By Inhalational (2021-2030) ($MN)
- Table 12 Global Chronic Cough Market Outlook, By Oral (2021-2030) ($MN)
- Table 13 Global Chronic Cough Market Outlook, By Injectable (2021-2030) ($MN)
- Table 14 Global Chronic Cough Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 15 Global Chronic Cough Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 16 Global Chronic Cough Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 17 Global Chronic Cough Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 18 Global Chronic Cough Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 19 Global Chronic Cough Market Outlook, By End User (2021-2030) ($MN)
- Table 20 Global Chronic Cough Market Outlook, By Speciality Centres (2021-2030) ($MN)
- Table 21 Global Chronic Cough Market Outlook, By Homecare (2021-2030) ($MN)
- Table 22 Global Chronic Cough Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 23 Global Chronic Cough Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 24 North America Chronic Cough Market Outlook, By Country (2021-2030) ($MN)
- Table 25 North America Chronic Cough Market Outlook, By Drug Class (2021-2030) ($MN)
- Table 26 North America Chronic Cough Market Outlook, By Antibiotics (2021-2030) ($MN)
- Table 27 North America Chronic Cough Market Outlook, By Acid Blockers (2021-2030) ($MN)
- Table 28 North America Chronic Cough Market Outlook, By Corticosteroids (2021-2030) ($MN)
- Table 29 North America Chronic Cough Market Outlook, By Decongestants (2021-2030) ($MN)
- Table 30 North America Chronic Cough Market Outlook, By Combination Drug (2021-2030) ($MN)
- Table 31 North America Chronic Cough Market Outlook, By Antihistamines (2021-2030) ($MN)
- Table 32 North America Chronic Cough Market Outlook, By Other Drug Classes (2021-2030) ($MN)
- Table 33 North America Chronic Cough Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 34 North America Chronic Cough Market Outlook, By Inhalational (2021-2030) ($MN)
- Table 35 North America Chronic Cough Market Outlook, By Oral (2021-2030) ($MN)
- Table 36 North America Chronic Cough Market Outlook, By Injectable (2021-2030) ($MN)
- Table 37 North America Chronic Cough Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 38 North America Chronic Cough Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 39 North America Chronic Cough Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 40 North America Chronic Cough Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 41 North America Chronic Cough Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 42 North America Chronic Cough Market Outlook, By End User (2021-2030) ($MN)
- Table 43 North America Chronic Cough Market Outlook, By Speciality Centres (2021-2030) ($MN)
- Table 44 North America Chronic Cough Market Outlook, By Homecare (2021-2030) ($MN)
- Table 45 North America Chronic Cough Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 46 North America Chronic Cough Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 47 Europe Chronic Cough Market Outlook, By Country (2021-2030) ($MN)
- Table 48 Europe Chronic Cough Market Outlook, By Drug Class (2021-2030) ($MN)
- Table 49 Europe Chronic Cough Market Outlook, By Antibiotics (2021-2030) ($MN)
- Table 50 Europe Chronic Cough Market Outlook, By Acid Blockers (2021-2030) ($MN)
- Table 51 Europe Chronic Cough Market Outlook, By Corticosteroids (2021-2030) ($MN)
- Table 52 Europe Chronic Cough Market Outlook, By Decongestants (2021-2030) ($MN)
- Table 53 Europe Chronic Cough Market Outlook, By Combination Drug (2021-2030) ($MN)
- Table 54 Europe Chronic Cough Market Outlook, By Antihistamines (2021-2030) ($MN)
- Table 55 Europe Chronic Cough Market Outlook, By Other Drug Classes (2021-2030) ($MN)
- Table 56 Europe Chronic Cough Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 57 Europe Chronic Cough Market Outlook, By Inhalational (2021-2030) ($MN)
- Table 58 Europe Chronic Cough Market Outlook, By Oral (2021-2030) ($MN)
- Table 59 Europe Chronic Cough Market Outlook, By Injectable (2021-2030) ($MN)
- Table 60 Europe Chronic Cough Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 61 Europe Chronic Cough Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 62 Europe Chronic Cough Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 63 Europe Chronic Cough Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 64 Europe Chronic Cough Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 65 Europe Chronic Cough Market Outlook, By End User (2021-2030) ($MN)
- Table 66 Europe Chronic Cough Market Outlook, By Speciality Centres (2021-2030) ($MN)
- Table 67 Europe Chronic Cough Market Outlook, By Homecare (2021-2030) ($MN)
- Table 68 Europe Chronic Cough Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 69 Europe Chronic Cough Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 70 Asia Pacific Chronic Cough Market Outlook, By Country (2021-2030) ($MN)
- Table 71 Asia Pacific Chronic Cough Market Outlook, By Drug Class (2021-2030) ($MN)
- Table 72 Asia Pacific Chronic Cough Market Outlook, By Antibiotics (2021-2030) ($MN)
- Table 73 Asia Pacific Chronic Cough Market Outlook, By Acid Blockers (2021-2030) ($MN)
- Table 74 Asia Pacific Chronic Cough Market Outlook, By Corticosteroids (2021-2030) ($MN)
- Table 75 Asia Pacific Chronic Cough Market Outlook, By Decongestants (2021-2030) ($MN)
- Table 76 Asia Pacific Chronic Cough Market Outlook, By Combination Drug (2021-2030) ($MN)
- Table 77 Asia Pacific Chronic Cough Market Outlook, By Antihistamines (2021-2030) ($MN)
- Table 78 Asia Pacific Chronic Cough Market Outlook, By Other Drug Classes (2021-2030) ($MN)
- Table 79 Asia Pacific Chronic Cough Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 80 Asia Pacific Chronic Cough Market Outlook, By Inhalational (2021-2030) ($MN)
- Table 81 Asia Pacific Chronic Cough Market Outlook, By Oral (2021-2030) ($MN)
- Table 82 Asia Pacific Chronic Cough Market Outlook, By Injectable (2021-2030) ($MN)
- Table 83 Asia Pacific Chronic Cough Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 84 Asia Pacific Chronic Cough Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 85 Asia Pacific Chronic Cough Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 86 Asia Pacific Chronic Cough Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 87 Asia Pacific Chronic Cough Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 88 Asia Pacific Chronic Cough Market Outlook, By End User (2021-2030) ($MN)
- Table 89 Asia Pacific Chronic Cough Market Outlook, By Speciality Centres (2021-2030) ($MN)
- Table 90 Asia Pacific Chronic Cough Market Outlook, By Homecare (2021-2030) ($MN)
- Table 91 Asia Pacific Chronic Cough Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 92 Asia Pacific Chronic Cough Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 93 South America Chronic Cough Market Outlook, By Country (2021-2030) ($MN)
- Table 94 South America Chronic Cough Market Outlook, By Drug Class (2021-2030) ($MN)
- Table 95 South America Chronic Cough Market Outlook, By Antibiotics (2021-2030) ($MN)
- Table 96 South America Chronic Cough Market Outlook, By Acid Blockers (2021-2030) ($MN)
- Table 97 South America Chronic Cough Market Outlook, By Corticosteroids (2021-2030) ($MN)
- Table 98 South America Chronic Cough Market Outlook, By Decongestants (2021-2030) ($MN)
- Table 99 South America Chronic Cough Market Outlook, By Combination Drug (2021-2030) ($MN)
- Table 100 South America Chronic Cough Market Outlook, By Antihistamines (2021-2030) ($MN)
- Table 101 South America Chronic Cough Market Outlook, By Other Drug Classes (2021-2030) ($MN)
- Table 102 South America Chronic Cough Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 103 South America Chronic Cough Market Outlook, By Inhalational (2021-2030) ($MN)
- Table 104 South America Chronic Cough Market Outlook, By Oral (2021-2030) ($MN)
- Table 105 South America Chronic Cough Market Outlook, By Injectable (2021-2030) ($MN)
- Table 106 South America Chronic Cough Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 107 South America Chronic Cough Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 108 South America Chronic Cough Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 109 South America Chronic Cough Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 110 South America Chronic Cough Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 111 South America Chronic Cough Market Outlook, By End User (2021-2030) ($MN)
- Table 112 South America Chronic Cough Market Outlook, By Speciality Centres (2021-2030) ($MN)
- Table 113 South America Chronic Cough Market Outlook, By Homecare (2021-2030) ($MN)
- Table 114 South America Chronic Cough Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 115 South America Chronic Cough Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 116 Middle East & Africa Chronic Cough Market Outlook, By Country (2021-2030) ($MN)
- Table 117 Middle East & Africa Chronic Cough Market Outlook, By Drug Class (2021-2030) ($MN)
- Table 118 Middle East & Africa Chronic Cough Market Outlook, By Antibiotics (2021-2030) ($MN)
- Table 119 Middle East & Africa Chronic Cough Market Outlook, By Acid Blockers (2021-2030) ($MN)
- Table 120 Middle East & Africa Chronic Cough Market Outlook, By Corticosteroids (2021-2030) ($MN)
- Table 121 Middle East & Africa Chronic Cough Market Outlook, By Decongestants (2021-2030) ($MN)
- Table 122 Middle East & Africa Chronic Cough Market Outlook, By Combination Drug (2021-2030) ($MN)
- Table 123 Middle East & Africa Chronic Cough Market Outlook, By Antihistamines (2021-2030) ($MN)
- Table 124 Middle East & Africa Chronic Cough Market Outlook, By Other Drug Classes (2021-2030) ($MN)
- Table 125 Middle East & Africa Chronic Cough Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 126 Middle East & Africa Chronic Cough Market Outlook, By Inhalational (2021-2030) ($MN)
- Table 127 Middle East & Africa Chronic Cough Market Outlook, By Oral (2021-2030) ($MN)
- Table 128 Middle East & Africa Chronic Cough Market Outlook, By Injectable (2021-2030) ($MN)
- Table 129 Middle East & Africa Chronic Cough Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 130 Middle East & Africa Chronic Cough Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 131 Middle East & Africa Chronic Cough Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 132 Middle East & Africa Chronic Cough Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 133 Middle East & Africa Chronic Cough Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 134 Middle East & Africa Chronic Cough Market Outlook, By End User (2021-2030) ($MN)
- Table 135 Middle East & Africa Chronic Cough Market Outlook, By Speciality Centres (2021-2030) ($MN)
- Table 136 Middle East & Africa Chronic Cough Market Outlook, By Homecare (2021-2030) ($MN)
- Table 137 Middle East & Africa Chronic Cough Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 138 Middle East & Africa Chronic Cough Market Outlook, By Other End Users (2021-2030) ($MN)
